This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1986 Nov-Dec;14(6):299-300.

doi: 10.1007/BF01643967.

Penetration of ciprofloxacin into human lung tissue following intravenous injection

D Schlenkhoff, A Dalhoff, J Knopf, W Opferkuch

PMID: 3818107
DOI: 10.1007/BF01643967

Penetration of ciprofloxacin into human lung tissue following intravenous injection

D Schlenkhoff et al. Infection. 1986 Nov-Dec.

. 1986 Nov-Dec;14(6):299-300.

doi: 10.1007/BF01643967.

Authors

D Schlenkhoff, A Dalhoff, J Knopf, W Opferkuch

PMID: 3818107
DOI: 10.1007/BF01643967

No abstract available

PubMed Disclaimer

Similar articles

Lung tissue concentrations of ciprofloxacin following intravenous administration in patients.
Forst H, Ruckdeschel G, Unertl K, Dieterich HJ, Ehret W, Sunder-Plassmann L. Forst H, et al. Arzneimittelforschung. 1989 May;39(5):618-9. Arzneimittelforschung. 1989. PMID: 2757681
Tissue penetration and metabolism of ciprofloxacin.
Wise R, Donovan IA. Wise R, et al. Am J Med. 1987 Apr 27;82(4A):103-7. Am J Med. 1987. PMID: 3578319
Penetration of ciprofloxacin into gynecologic tissues.
Dalhoff A, Weuta H. Dalhoff A, et al. Am J Med. 1987 Apr 27;82(4A):133-8. Am J Med. 1987. PMID: 3555027 Review.
The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
Bacracheva N, Scholl H, Gerova Z, Chervenakov P, Dobrev P, Vlahov V. Bacracheva N, et al. Int J Clin Pharmacol Ther Toxicol. 1991 Sep;29(9):352-6. Int J Clin Pharmacol Ther Toxicol. 1991. PMID: 1937996 Clinical Trial.
The selection of appropriate dosages for intravenous ciprofloxacin.
Echols RM. Echols RM. J Antimicrob Chemother. 1993 May;31(5):783-7. doi: 10.1093/jac/31.5.783. J Antimicrob Chemother. 1993. PMID: 8335506 Review.

See all similar articles

Cited by

Role of quinolones in the treatment of bronchopulmonary infections, particularly pneumococcal and community-acquired pneumonia.
Thys JP, Jacobs F, Byl B. Thys JP, et al. Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):304-15. doi: 10.1007/BF01967004. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1864291 Review.
Pharmacokinetics of ciprofloxacin.
Bergan T, Dalhoff A, Rohwedder R. Bergan T, et al. Infection. 1988;16 Suppl 1:S3-13. doi: 10.1007/BF01650500. Infection. 1988. PMID: 3286512 Review.
Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.
Roosendaal R, Bakker-Woudenberg IA, van den Berghe-van Raffe M, Vink-van den Berg JC, Michel MF. Roosendaal R, et al. Antimicrob Agents Chemother. 1987 Nov;31(11):1809-15. doi: 10.1128/AAC.31.11.1809. Antimicrob Agents Chemother. 1987. PMID: 3324962 Free PMC article.
Concentration of ciprofloxacin in human serum, lung and pleural tissues and fluids during and after lung surgery.
Hopf G, Böcker R, Estler CJ, Radtke HJ, Floh W. Hopf G, et al. Infection. 1988;16(1):29-30. doi: 10.1007/BF01646928. Infection. 1988. PMID: 3360495 No abstract available.
Ciprofloxacin therapy of respiratory tract infection with Pseudomonas aeruginosa.
Haverkorn MJ. Haverkorn MJ. Eur J Clin Microbiol Infect Dis. 1988 Oct;7(5):661-4. doi: 10.1007/BF01964247. Eur J Clin Microbiol Infect Dis. 1988. PMID: 3143577

See all "Cited by" articles

References

1. Infection. 1985 Mar-Apr;13(2):78-81 - PubMed
1. Br Med J. 1978 Jun 24;1(6128):1657-60 - PubMed
1. J Antimicrob Chemother. 1984 Apr;13(4):333-46 - PubMed
1. Br Med J (Clin Res Ed). 1982 May 29;284(6329):1597-9 - PubMed
1. Eur J Clin Microbiol. 1986 Apr;5(2):193-6 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions